Masimo Corporation has announced the findings of a new clinical trial, published in JAMA Pediatrics, demonstrating the advantages of its SedLine® Brain Function Monitoring technology in pediatric anesthesia. The study, conducted by Dr. Yasuko Nagasaka and colleagues at Tokyo Women's Medical University, involved children aged 1 to 6 years undergoing elective surgery. The results showed that EEG-guided anesthesia using SedLine significantly reduced the exposure to sevoflurane, a commonly used inhalation anesthetic, and lowered the incidence of pediatric anesthesia emergence delirium (PAED). Children monitored with SedLine regained consciousness 53% sooner and were discharged from the post-anesthesia care unit 48% sooner compared to those in the control group. These outcomes suggest improvements in safety, efficiency, and cost-effectiveness of pediatric anesthesia. The findings have been presented and are available for review.